Researchers identify protein mutation that alters tissue development in males before birth

November 19, 2014

Case Western Reserve researchers have identified a protein mutation that alters specific gender-related tissue in males before birth and can contribute to the development of cancer as well as other less life-threatening challenges.

The discovery marks the latest in a series of findings related to the protein SRY (sex-determining region on the Y chromosome), which serves as a master switch for ensuring typical human male maturation. In this case, however, the mutation prevents the protein from folding properly and in turn impairs the protein's ability to direct the appropriate development of gonadal tissue. Even worse, the tissue defects in the original patient identified with this mutation also contribute to the development of gonadal cancer. The findings appear in the November 21 edition of the Journal of Biological Chemistry, whose editors named the article its Paper of the Week.

Case Western Reserve biochemistry doctoral student Joseph Racca is senior author of the piece, which describes the protein's infrastructure with architectural terms typically reserved for historic European churches.

"The mutation occurs in a strategic part of the SRY protein that we describe as an 'aromatic buttress' -- molecular struts and girders that function in support of an angular DNA-bending surface," Racca explained. "Just as the flying buttresses of Gothic cathedrals ensure their structural stability, the aromatic buttress of SRY is responsible for proper protein folding and stability."

Racca is a student in the laboratory of Michael Weiss, MD, PhD, the chair of biochemistry and a co-author of this paper. Weiss has led a team of scientists through the discovery of multiple unique aspects of the SRY protein mutations, each with its own signature of defects in structure and function.

"The DNA-bending module of the SRY protein is preserved among a large family of regulatory proteins that regulate key events in development, including how stem cells form the brain and other organs," said Weiss, also a Distinguished Research Professor within the medical school.

Regulatory proteins, first discovered in 1992 by Robin Lovell-Badge, PhD, and colleagues at the Medical Research Council in London, England, have attracted growing interest in terms of birth defects and cancer. SRY is considered the pivotal protein in regulating male sex determination.

Mutations in the SRY protein take place within an L-shaped protein architecture known as a high mobility group (HMG) box. The HMG box is a structure that contains chromosomal proteins that regulate DNA processes such as transcription, replication, recombination and DNA repair.

Mutations in the HMG box of the aromatic buttress essentially place a hole at a strategic point in the L shape, resulting in its collapse. The collapse leads to incomplete folding and binding with the DNA and affects all the various functions of male sex determination in humans.

"At the start of this project, we speculated that this mutation would be unfavorable," Racca said. "But we underestimated the extent and range of impairments. A 'perfect storm' leads to the collapse of almost all the molecular functions of SRY, including cellular trafficking, stability, DNA recognition and gene regulation."

Mutations in SRY alter the dynamics of male development during fetal life. In most cases, mutations lead to XY sex reversal, a syndrome in which babies are born with a female appearance, including external genitalia, uterus and fallopian tubes. When these patients fail to menstruate at the onset of puberty, an XY chromosome may be discovered. This condition is designated 46, XY pure gonadal dysgenesis with female somatic phenotype (Swyer's syndrome, affecting one in 80,000 births). In some cases, SRY mutations cause a continuum of disorders of sex development, including pseudohermaphroditism (affecting up to 1 in 99,000 births) with partial ovarian and testicular differentiation within the intra-abdominal gonads. Impaired differentiation of the gonads confers high risk of a pediatric cancer, gonadoblastoma.

"Beyond its specific role in testicular differentiation," Racca said, "SRY illustrates general principles of protein structure and evolution."

As for next research steps, the investigators will seek to exploit the SRY database and its evolutionary linkages to other SOX transcription factors to explore applications to stem-cell biology and cancer. SOX stands for Sry-related HMG box, and SOX genes activate a family of transcription factors that bind to the minor grooves in DNA.

Racca and his fellow researchers represent the potential power of multidisciplinary collaboration as exemplified in the study of this mutation.

"Our team at Case Western Reserve is a great group of scientists and friends with complementary interests," said Racca. "My work focuses on the molecular functions of SRY as a biophysical system, for example, while one bench away is a classmate who monitors the biological effects of mutations in a mammalian cell-culture system. Together, we related how biophysical and biochemical properties affected by the SRY mutation relate to the regulation of a gene-regulatory network in a biological system."
-end-
Collaborating with Weiss and Racca on this SRY mutation research were Yen-Shan Chen, PhD, James D. Maloy, Nalinda Wickramasinghe, PhD, and associate professor Nelson B. Phillips, PhD, all of the Department of Biochemistry, Case Western Reserve University School of Medicine.

This work was supported in part by a grant to Michael A. Weiss, MD, from the National Institutes of Health (GM080505) and represents a contribution from the Cleveland Center for Membrane & Structural Biology. Patricia K. Donahoe, MD, of the Massachusetts General Hospital and Harvard Medical School, Boston, generously provided rodent embryonic CH34 cells for the project.

About Case Western Reserve University School of Medicine


Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.

Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research-oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."

The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu

Case Western Reserve University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.